MyAverix Finance
KQ · Healthcare
HLB Pharmaceutical Co. Ltd (047920)
Drug Manufacturers - Specialty & Generic
HLB Pharmaceutical Co. Ltd (047920) is listed on KQ in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 047920
HLB Pharmaceutical Co. Ltd (047920) — FAQ
What is 047920's P/E ratio?
The price-to-earnings (P/E) ratio for HLB Pharmaceutical Co. Ltd (047920) is 18.00 (data as of 2026-03-24).
Does HLB Pharmaceutical Co. Ltd pay a dividend?
Dividend yield is not available in the current snapshot for HLB Pharmaceutical Co. Ltd (047920). Check the MyAverix Finance app for the latest dividend data.
What sector is HLB Pharmaceutical Co. Ltd in?
HLB Pharmaceutical Co. Ltd (047920) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 047920 listed on?
047920 is listed on KQ.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.